Rinvoq ER 30 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9MF1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,730
Award facts
- Contract value 100% obligated
- $15,729.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a competitive delivery order valued at $15,729.71 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-unit quantity) with a completion date of January 22, 2026. This non-set-aside contract represents a firm fixed-price order executed on January 21, 2026, with performance fulfilled at the contractor's Conshohocken, Pennsylvania headquarters. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs across the Department of Defense and related agencies.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The overarching IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. Through this contract vehicle and its open competition status, AmerisourceBergen demonstrates its capability to meet federal pharmaceutical procurement requirements for military treatment facilities, veterans' healthcare programs, and other government medical institutions.
Quick answers
Who was awarded contract SPE2DR26F9MF1?
SPE2DR26F9MF1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F9MF1 worth?
The government has obligated $15,730 on SPE2DR26F9MF1.
Is contract SPE2DR26F9MF1 an order under another contract?
Yes. SPE2DR26F9MF1 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9MF1 competed?
The extent of competition for SPE2DR26F9MF1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award